Attention Deficit Hyperactivity Disorder Clinical Trial
Official title:
Effects of Aerobic Exercise Intervention in Adolescents With Attention-deficit/Hyperactivity Disorder (ADHD)
The goal of this clinical trial is to investigate the neurophysiological foundation of the impact of the acute effects of controlled aerobic exercise intensity in adolescents with ADHD, its involvement in cognitive processes, and clinical outcomes in respect to executive functions. The main questions it aims to answer are: - To find out the effects of a single bout of aerobic exercise intervention on neurophysiology and executive functions in adolescents with ADHD - To examine the relationship between neurophysiology and executive functions following a single bout of aerobic exercise intervention Participants will be asked to do three different executive function tasks regarding inhibitory control, working memory and cognitive planning and receive the evaluation of motor cortex excitability via transcranial magnetic stimulation (TMS) before and after a single bout of 30-min aerobic cycling exercise of moderate intensity. Researchers will compare the control group with 30-min video-watching to see if effects of a single bout of aerobic exercise intervention on neurophysiology and executive functions in adolescents with ADHD.
Status | Recruiting |
Enrollment | 90 |
Est. completion date | October 1, 2025 |
Est. primary completion date | October 1, 2025 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 13 Years to 17 Years |
Eligibility | Inclusion Criteria: - Diagnosis of ADHD by a board-certified psychiatrist according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-V) - Adolescents aged between 13-17 - Absence of other neuropsychological disorders including, autism spectrum disorders, mental retardation, psychotic disorders, bipolar disorders, obsessive-compulsive disorder, and neurocognitive disorders - Right-handed Exclusion Criteria: - Presence of other major systematical diseases - Taking neuropsychological medication within one month, except for medication for ADHD - With contraindications for non-invasive brain stimulation such as epilepsy, pacemaker or intracranial mental implants - Color blindness - Taking part in other studies within one month. |
Country | Name | City | State |
---|---|---|---|
Taiwan | Neurophysiology and Cognition in Children and Young Adults Lab, School and Graduate Institute of Physical Therapy of National Taiwan University (NTU-PT) | Taipei county |
Lead Sponsor | Collaborator |
---|---|
National Taiwan University Hospital |
Taiwan,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Stop Signal Task (SST) | The test will require participants to respond to an arrow stimulus pointing in a given direction. The first set incorporates 16 trials where the participants practice the response. In the second set, the participants will be told to inhibit their response if they heard an auditory signal (a beep). An adaptive staircase will be employed for the stop signal delay allowing the task to adapt to the performance of the participant to result in a 50% success rate. An inter-stimulus interval of 1,000 ms will be applied. The outcome measures are the stop signal reaction time, the estimate of when an individual can successfully inhibit their response 50% of the time. This is inferred as the time before all actions become ballistic, and the person is no longer able to stop the action | Pre-intervention/immediately after the intervention | |
Primary | Spatial Working Memory (SWM) task | The SWM task is based on a self-ordered search test and assesses primarily nonverbal working memory. Participants are asked to search through a number of colored boxes presented on the screen to find a different token hidden inside. Each box housed only one token per trial. Searching a box more than once during a sequence resulted in within errors, and returning to an emptied box resulted in between errors. A double error could be categorized as both a within and a between error. Two major indices are presented: (1) strategy utilization: the number of search sequences starting with a novel box in both 6- and 8-box problems, and (2) errors in total and three different levels of difficulty (4-, 6-, and 8-box problems): the total errors were calculated as the sum of between errors and within errors minus double errors for searches. | Pre-intervention/immediately after the intervention | |
Primary | Stockings of Cambridge (SOC) | The SOC requires participants to plan and execute a set of movements to replicate a goal arrangement of balls. At the beginning of each trial, there are two displays shown on the screen simultaneously, and three suspended vertical stockings and three colored balls are presented. Participants are asked to move the colored balls in a single move at a time between the stockings, to correspond to a goal position shown in the top display within a specified number of moves (2, 3, 4, and 5 moves). In the control condition, they are required to follow the ball movements as quickly as possible to provide baseline measures of reaction and movement times, with each trial being an exact replication of their earlier planning moves. Three major indices are presented: (1) number of problems solved in the specified minimum number of moves; (2) mean moves: the number of moves taken in excess of the specified minimum number, but within the maximum allowed | Pre-intervention/immediately after the intervention | |
Primary | TMS parameters: Motor evoked potential (MEP) | TMS is applied with a figure-of-eight coil with an internal diameter of 70mm connected to a Magstim stimulator (Magstim, Whiteland, Dyfed, UK), which generates a strong, short-lasting magnetic stimulus. It induces an electric current flow in the motor cortex sufficient to activate neurons at the suprathreshold level, shown as MEP of the representational muscle. Surface MEPs is recorded from the right abductor digiti minimi muscle (ADM) with an Ag-AgCl electrode in a belly-tendon montage. The signals will be filtered (2Hz to 2 kHz, sampling rate 5 kHz), amplified, and then stored on a computer via a Power 1401 data acquisition interface (Cambridge Electronic Design, Cambridge, UK).
The peak-to-peak amplitude of the MEP is defined as the overall response of the ADM induced by stimulating the contralateral motor cortex by TMS. The mean MEP is averaged in at least 15 trials and recorded as milli voltage. |
Pre-intervention/immediately after the intervention | |
Primary | TMS parameters: Resting motor threshold (RMT) | RMT is defined as the minimum TMS intensity that elicits a peak-to-peak MEP of 50~100 microvoltage (µV) in the relaxed muscle in at least three of six consecutive trials. RMT is recorded by the intensity of TMS presented by percentage (0-100%). The higher percentage represents a stronger intensity to elicit RMT. | Pre-intervention/immediately after the intervention | |
Primary | TMS parameters: Active motor threshold (AMT) | AMT is the minimum intensity eliciting an MEP response of 200~300 microvoltage (µV) during moderate spontaneous background muscle activity (~15% of the maximum muscle strength) in at least three of six consecutive trials. AMT is recorded by the intensity of TMS presented by percentage (0-100%). The higher percentage represents a stronger intensity to elicit AMT. | Pre-intervention/immediately after the intervention | |
Primary | TMS parameters: Short-interval intracortical inhibition (SICI) and intracortical facilitation (ICF) | In the SICI-ICF protocol, a subthreshold conditioning stimulus (determined as 70 % of AMT) precedes the test stimulus (determined as baseline MEP of ~1mV) with the interstimulus intervals (ISIs) of 2, 3, 5, 10, and 15ms. The first three ISIs reflect inhibitory and the last two ISIs reveal facilitatory effects. The pairs of stimuli are organized into 15 blocks. Each block contains double pulses with all ISIs, and one additional single test pulse in a pseudo-randomized order for each block. SICI is mainly influenced by GABAA receptors and ICF is thought to predominantly reflect the activity of the glutamatergic system, with some GABAA contribution. The SICI-ICF is presented as the subtraction of the conditioning stimulus by the test stimulus. | Pre-intervention/immediately after the intervention |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04779333 -
Lifestyle Enhancement for ADHD Program 2
|
N/A | |
Recruiting |
NCT05935722 -
Evaluation of a Home-based Parenting Support Program: Parenting Young Children
|
N/A | |
Completed |
NCT03148782 -
Brain Plasticity Underlying Acquisition of New Organizational Skills in Children-R61 Phase
|
N/A | |
Completed |
NCT04832737 -
Strength-based Treatment Approach for Adults With ADHD
|
N/A | |
Recruiting |
NCT04631042 -
Developing Brain, Impulsivity and Compulsivity
|
||
Recruiting |
NCT05048043 -
Development of a Game-supported Intervention
|
N/A | |
Completed |
NCT03337646 -
Evaluation of the Effect and Safety of Lisdexamfetamine in Children Aged 6-12 With ADHD and Autism
|
Phase 4 | |
Not yet recruiting |
NCT06406309 -
Settling Down for Sleep in ADHD: The Impact of Sensory and Arousal Systems on Sleep in ADHD
|
N/A | |
Not yet recruiting |
NCT06080373 -
Formulation-based CBT for Adult Inmates With ADHD: A Randomized Controlled Trial
|
N/A | |
Not yet recruiting |
NCT06454604 -
Virtual Reality Treatment for Emerging Adults With ADHD
|
Phase 2 | |
Completed |
NCT02477280 -
Effects of Expectation, Medication and Placebo on Objective and Self-rated Performance
|
Phase 4 | |
Completed |
NCT02911194 -
a2 Milk for Autism and Attention-deficit Hyperactivity Disorder (ADHD)
|
N/A | |
Completed |
NCT02473185 -
Effects of Expectation, Medication and Placebo on Objective and Self-rated Performance During the QbTest
|
Phase 4 | |
Completed |
NCT02780102 -
Cognitive-Motor Rehabilitation, Stimulant Drugs, and Active Control in the Treatment of ADHD
|
N/A | |
Completed |
NCT02829970 -
Helping College Students With ADHD Lead Healthier Lifestyles
|
N/A | |
Completed |
NCT02555150 -
A Comparison of PRC-063 and Lisdexamfetamine in the Driving Performance of Adults With ADHD
|
Phase 3 | |
Completed |
NCT02390791 -
New Technologies to Help Manage ADHD
|
N/A | |
Recruiting |
NCT04175028 -
Neuromodulation of Executive Function in the ADHD Brain
|
N/A | |
Recruiting |
NCT04296604 -
Transcranial Direct Current Stimulation (tDCS) Neuromodulation of Executive Function Across Neuropsychiatric Populations
|
N/A | |
Completed |
NCT02251080 -
Attention Deficit/Hyperactivity Disorder Internet Survey Study in a College Student Population
|
N/A |